Mapelli; Claudio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mapelli; Claudio.The latest application filed is for "modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof".

Company Profile

8.24.34

Mapelli; Claudio - Linden NJ
Mapelli; Claudio - Princeton NJ
Mapelli; Claudio - Plainsboro NJ
Mapelli; Claudio - Langhorne PA
Mapelli; Claudio - Lawrenceville NJ
Mapelli; Claudio - Yardley PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof App 20220211812 - Dubowchik; Gene M. ; et al.	2022-07-07
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof Grant 11,364,281 - Dubowchik , et al. June 21, 2	2022-06-21
Immunomodulators Grant 11,358,988 - Gillman , et al. June 14, 2	2022-06-14
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof Grant 11,224,634 - Dubowchik , et al. January 18, 2	2022-01-18
Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides Grant 11,185,570 - Dubowchik , et al. November 30, 2	2021-11-30
Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof App 20210196791 - Dubowchik; Gene M. ; et al.	2021-07-01
Immunoassay standards and measurement of tau using intra-assay calibration standards Grant 10,823,739 - Rhyne , et al. November 3, 2	2020-11-03
Immunomodulators App 20200216498 - GILLMAN; Kevin W. ; et al.	2020-07-09
Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards Grant 10,670,612 - Rhyne , et al.	2020-06-02
Immunomodulators Grant 10,633,419 - Gillman , et al.	2020-04-28
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions Grant 10,538,555 - Miller , et al. Ja	2020-01-21
Immunomodulators Grant 10,450,347 - Miller , et al. Oc	2019-10-22
Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof App 20190256570 - Dubowchik; Gene M. ; et al.	2019-08-22
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof Grant 10,266,578 - Dubowchik , et al.	2019-04-23
Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof App 20180222960 - DUBOWCHIK; Gene M. ; et al.	2018-08-09
Immunomodulators App 20180086793 - Gillman; Kevin W. ; et al.	2018-03-29
Immunomodulators Grant 9,861,680 - Mapelli , et al. January 9, 2	2018-01-09
Immunomodulators Grant 9,856,292 - Gillman , et al. January 2, 2	2018-01-02
Macrocyclic Inhibitors Of The Pd-1/pd-l1 And Cd80(b7-1)/pd-l1 Protein/protein Interactions App 20170369530 - Miller; Michael Matthew ; et al.	2017-12-28
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions Grant 9,850,283 - Miller , et al. December 26, 2	2017-12-26
Immunomodulators App 20170283462 - Miller; Michael Matthew ; et al.	2017-10-05
Macrocyclic Inhibitors Of The Pd-1/pd-l1 And Cd80(b7-1)/pd-l1 Protein/protein Interactions App 20170260237 - Miller; Michael Matthew ; et al.	2017-09-14
PAR4 agonist peptides Grant 9,605,024 - Kornacker , et al. March 28, 2	2017-03-28
Immunoassay Standards And Measurement Of Clinical Biomarkers Using Intra-assay Calibration Standards App 20170082641 - Rhyne; Paul ; et al.	2017-03-23
Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards Grant 9,482,665 - Rhyne , et al. November 1, 2	2016-11-01
Par4 Agonist Peptides App 20160304560 - KORNACKER; Michael G. ; et al.	2016-10-20
Immunomodulators App 20160222060 - Miller; Michael Matthew ; et al.	2016-08-04
Immunomodulators App 20160175386 - Mapelli; Claudio ; et al.	2016-06-23
Macrocyclic Inhibitors Of The Pd-1/pd-l1 And Cd80(b7-1)/pd-l1 Protein/protein Interactions App 20160158349 - Miller; Michael Matthew ; et al.	2016-06-09
Immunomodulators App 20160137696 - Gillman; Kevin W. ; et al.	2016-05-19
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions Grant 9,308,236 - Miller , et al. April 12, 2	2016-04-12
PAR4 agonist peptides Grant 9,303,065 - Kornacker , et al. April 5, 2	2016-04-05
Immunoassay Standards And Measurement Of Tau Using Intra-assay Calibration Standards App 20160033525 - Rhyne; Paul ; et al.	2016-02-04
Par4 Agonist Peptides App 20150158910 - KORNACKER; Michael G. ; et al.	2015-06-11
Immunoassay Standards And Measurement Of Clinical Biomarkers Using Intra-assay Calibration Standards App 20150153339 - Rhyne; Paul ; et al.	2015-06-04
PAR4 agonist peptides Grant 8,927,688 - Kornacker , et al. January 6, 2	2015-01-06
Macrocyclic Inhibitors Of The Pd-1/pd-l1 And Cd80(b7-1)/pd-l1 Protein/protein Interactions App 20140294898 - Miller; Michael Matthew ; et al.	2014-10-02
Par4 Agonist Peptides App 20130289238 - Kornacker; Michael G. ; et al.	2013-10-31
Immunoassay Standards And Measurement Of Clinical Biomarkers Using Intra-assay Calibration Standards App 20120309028 - Rhyne; Paul ; et al.	2012-12-06
N-terminally modified GLP-1 receptor modulators Grant 7,960,349 - Ewing , et al. June 14, 2	2011-06-14
Human Glucagon-like Peptide-1 Mimics And Their Use In The Treatment Of Diabetes And Related Conditions App 20100210552 - Natarajan; Sesha Iyer ; et al.	2010-08-19
Sustained release glp-1 receptor modulators App 20100022457 - Qian; Feng ; et al.	2010-01-28
Sustained release GLP-1 receptor modulators Grant 7,534,763 - Qian , et al. May 19, 2	2009-05-19
Human Glucagon-like-peptide-1 Modulators And Their Use In The Treatment Of Diabetes And Related Conditions App 20080242593 - Ewing; William R. ; et al.	2008-10-02
Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions Grant 7,417,028 - Ewing , et al. August 26, 2	2008-08-26
N-terminally Modified Glp-1 Receptor Modulators App 20080045461 - Ewing; William R. ; et al.	2008-02-21
Beta secretase exosite binding peptides and methods for identifying beta secretase modulators Grant 7,314,726 - Kornacker , et al. January 1, 2	2008-01-01
Human Glucagon-like Peptide-1 Mimics And Their Use In The Treatment Of Diabetes And Related Conditions App 20070287670 - Natarajan; Sesha Iyer ; et al.	2007-12-13
Human Glucagon-like-peptide-1 Modulators And Their Use In The Treatment Of Diabetes Related Conditions App 20070238669 - Haque; Tasir Shamsul ; et al.	2007-10-11
Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions Grant 7,238,670 - Natarajan , et al. July 3, 2	2007-07-03
Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions Grant 7,238,671 - Natarajan , et al. July 3, 2	2007-07-03
Beta secretase exosite binding peptides and methods for identifying beta secretase modulators App 20070149763 - Kornacker; Michael G. ; et al.	2007-06-28
Sustained release GLP-1 receptor modulators App 20070099835 - Qian; Feng ; et al.	2007-05-03
N-terminally modified GLP-1 receptor modulators App 20070021346 - Ewing; William R. ; et al.	2007-01-25
Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions App 20060287242 - Ewing; William R. ; et al.	2006-12-21
Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions App 20040127423 - Natarajan, Sesha Iyer ; et al.	2004-07-01
Beta secretase exosite binding peptides and methods for identifying beta secretase modulators App 20040121412 - Kornacker, Michael G. ; et al.	2004-06-24
Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions App 20030195157 - Natarajan, Sesha Iyer ; et al.	2003-10-16